Testing a medicine reminder app for blood pressure, diabetes and cholesterol
Tests a phone app that reminds adults with these conditions to take medicine.
Plain-language title generated from the registry record
Registry title: Implementation and Effectiveness of "CareAide® App" for People with Cardiometabolic Diseases At a Primary Care Clinic
Key facts
- Where
- Petaling Jaya, MalaysiaSee the site
Where in Malaysia
- Universiti Malaya Medical CentrePetaling Jaya, MalaysiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Malaya
- Trial code
- NCT06779591
- Record updated
- 30 March 2025
- Original description
This study aims to explore the barriers and facilitators to implement CareAide® app among healthcare providers and patients at a primary care clinic in Malaysia.Read full original descriptionShow less
Implementation and Effectiveness of the Medication Adherence "CareAide® App" for People with Cardiometabolic Diseases At an Academic Primary Care Clinic in Malaysia: a Hybrid Implementation-effectiveness Study
This study aims to explore the barriers and facilitators to implement CareAide® app among healthcare providers and patients at a primary care clinic in Malaysia.
This is an implementation-qualitative research study meaning researchers will collect data regarding the adoption rate, ease of implementation and adoption, and patient's willingness to use the application. The researchers will also compare the effectiveness of the application as a tool to remind patients to take their medicine, by comparing between a group of participants who use the app and another group of participants who do not use the app.
This study requires participants to use an app, then attend some routine follow-ups and be administered blood tests, followed by an interview to collect their opinions, feelings, and experiences.
Inclusion: Above 18 years old; Medically diagnosed with either hypertension, type 2 diabetes and dyslipidemia for at least 6 months as listed in electronic health records; Exhibit a low adherence indicated by Malaysia Medication Adherence Assessment Tool (MyMAAT) scores of <54 scores; Taking at least one type of medication daily, three medications daily or two medications with multiple dosing intervals prescribed,; Owns and able to use a smartphone; Able to read English or Malay.
Exclusion: Individuals who are pregnant, already using any adherence apps or diagnosed with any terminal illnesses, visually impaired, disability or mental health related illnesses.